The use of pindolol to potentiate antidepressant medication

Journal of Clinical Psychiatry

Volumn 59, Issue SUPPL. 5, 1998, Pages 16-25

  Blier, Pierre ^a   Bergeron, Richard ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BUSPIRONE; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE MALEATE; IMIPRAMINE; METOPROLOL TARTRATE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; PAROXETINE; PHENELZINE; PINDOLOL; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRIMIPRAMINE;

ARTICLE; BETA ADRENERGIC STIMULATION; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; ENZYME INHIBITION; HUMAN; NEUROTRANSMISSION; POSTSYNAPTIC INHIBITION; PRIORITY JOURNAL; RATING SCALE; RECEPTOR BLOCKING;

ANIMALS; ANTIDEPRESSIVE AGENTS; AUTORECEPTORS; CONTROLLED CLINICAL TRIALS; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MONOAMINE OXIDASE INHIBITORS; PINDOLOL; RATS; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0031864268     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. de Montigny C, Chaput Y, Blier P. Classical and novel targets for antidepressant drugs. International Academy of Biomedical Drug Research 1993; 5:8-17
2. Artigas F, Perez V, Alvarez E. Pindolol induces a rapid improvement of depressed patients with serotonin reuptake inhibitors [letter]. Arch Gen Psychiatry 1994;51:248-251
3. Blier P, Bergeron R. Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol 1995; 15:217-222
4. Avorn J, Everitt DE, Weiss S. Increased antidepressant use in patients prescribed β-blockers. JAMA 1986;255:357-360
5. Blier P, de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol Sci 1994;15:220-226
6. de Montigny C, Aghajanian GK. Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin. Science 1978;202:1303-1306
7. Menkes DB, Aghajanian GK, McCall RB. Chronic antidepressant treatment enhances α-adrenergic and serotonergic responses in the facial nucleus. Life Sci 1980;27:45-55
8. de Montigny C. Electroconvulsive shock treatments enhance responsiveness of forebrain neurons to serotonin. J Pharmacol Exp Ther 1984;228: 230-234
9. Chaput Y, de Montigny C, Blier P. Presynaptic and postsynaptic modifications of the serotonin system by long-term antidepressant treatments: electrophysiological studies in the rat brain. Neuropsychopharmacology 1991; 5:219-229
10. Blier P, de Montigny C. Electrophysiological studies on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat. J Neurosci 1983;3:1270-1278
11. Blier P, de Montigny C. Serotonergic but not noradrenergic neurons in rat CNS adapt to long-term treatment with monoamine oxidase inhibitors. Neuroscience 1985;16:949-955
12. 1A agonist gepirone: electrophysiological studies in the rat brain. Synapse 1987;1:470-480
13. Blier P, de Montigny C, Azzaro AJ. Modification of serotonergic and noradrenergic neurotransmission by repeated administration of monoamine oxidase inhibitors: electrophysiological studies in the rat CNS. J Pharmacol Exp Ther 1986;227:987-994
14. Chaput Y, de Montigny C, Blier P. Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat. Naunyn Schmiedebergs Arch Pharmacol 1986; 333:342-348
15. Blier P, Bouchard C. Modulation of serotonin release in the guinea pig brain following long-term administration of antidepressant drugs. Br J Pharmacol 1994;113:485-495
16. 1A receptors in the dorsal raphe and hippocampus, I: effect of spiperone. J Pharmacol Exp Ther 1993;265:7-15
17. 1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain. Neuropsychopharmacology 1996;15:349-360
18. 1A antagonist. Behav Brain Res 1996;73:337-353
19. El Mansari M, Blier P. In vivo electrophysiological characterization of 5-HT receptors in the guinea pig head of caudate nucleus and orbitofrontal cortex. Neuropharmacology 1997;36:577-588
20. Haddjeri N, de Montigny C, Blier P. Modulation of the firing activity of norepinephrine neurons in the locus coeruileus by the serotonin system. Br J Pharmacol 1997;120:865-875
21. Viñar O, Vinarova E, Horacek J. Pindolol accelerates the therapeutic action of selective serotonin reuptake inhibitors (SSRI) in depression. Homeostasis 1996;37:93-95
22. Bakish D, Hooper CL, Thornton M, et al. Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy. Int Clin Psychopharmacol 1997;12:91-98
23. 1A receptors produces a rapid antidepressant response. Neuropsychopharmacology 1997;16:333-338
24. 1A receptors: a future direction in the pharmacotherapy of affective disorders? In: Meltzer HY, Nerozzi D, eds. Current Practices and Future Developments in the Pharmacotherapy of Mental Disorders. Amsterdam, The Netherlands: Elsevier; 1991:99-104
25. Zanardi R, Artigas F, Franchini L, et al. How long should pindolol be associated with paroxetine to improve the antidepressant response? J Clin Psychopharmacol 1997;17:446-450
26. Perez V, Gilaberte I, Faries D, et al. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment. Lancet 1997;349:1594-1597
27. Tome MB, Isaac MT, Harte R, et al. Paroxetine and pindolol: a randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency. Int Clin Psychopharmacol 1997;12:81-90
28. Thomas P, Bordet R, Thomas JY, et al. Pindolol addition shortens delay of action of paroxetine in major depression: a double blind controlled trial [abstract]. Eur Neuropsychopharmacol 1997;7(suppl 2):173
29. Berman RM, Darnell AM, Miller HL, et al. Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial. Am J Psychiatry 1997;154:37-43
30. Blier P, Bergeron R. Sequential administration of augmentation strategies in treatment-resistant obsessive-compulsive disorder: preliminary findings. Int Clin Psychopharmacol 1996;11:37-44
31. Maes M, Vandoolaeghe E, Desnyder R. Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression. J Affect Disord 1996;41:201-210
32. Moreno FA, Delgado PL, Bachar K, et al. Pindolol augmentation in treatment-resistant depressed patients. Psychopharmacol Bull 1996;32:492